NQO1/p65/CXCL12 Axis‐Recruited Tregs Mediate Resistance to Anti‐PD‐1 Plus Lenvatinib Therapy in PIVKA‐II‐Positive Hepatocellular Carcinoma.

Saved in:
Bibliographic Details
Title: NQO1/p65/CXCL12 Axis‐Recruited Tregs Mediate Resistance to Anti‐PD‐1 Plus Lenvatinib Therapy in PIVKA‐II‐Positive Hepatocellular Carcinoma.
Authors: Gao, Biao1,2,3, Wang, Yafei4, Sun, Zhuoya5,6, Tang, Haowen1,2,3, Cao, Yinbiao1,2,3,5, Jiang, Hao1,2,3, Zhang, Wenwen1,2,3, Xu, Yinzhe1,2,3, Hu, Bingyang7, Liu, Zhe1,2,3, Mao, Guankun1,2,3, Li, Xuerui1,2,3, Li, Junfeng1,2,3, Wan, Tao8, Liu, Bing1,2,3, Zhao, Xiao6, zhaoxiao@301hospital.com.cn, Jiao, Shunchang6, jiaoshunchang@301hospital.com.cn, Li, Chonghui1,2,3, lichonghui@301hospital.com.cn, Lu, Shichun1,2,3, lushichun@301hospital.com.cn
Source: Advanced Science; 12/11/2025, Vol. 12 Issue 46, p1-18, 18p
Database: Applied Science & Technology Source
Full text is not displayed to guests.
Description
ISSN:21983844
DOI:10.1002/advs.202511152